Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
02 2020
Historique:
received: 09 07 2019
accepted: 03 11 2019
pubmed: 30 11 2019
medline: 6 11 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Prevalence and prognostic impact of cardiovascular disease differ between patients with or without diabetes. We aimed to explore differences in the prevalence and prognosis of myocardial ischemia by automated quantification of total perfusion deficit (TPD) among patients with and without diabetes. Of 20,418 individuals who underwent single-photon emission computed tomography myocardial perfusion imaging, 2,951 patients with diabetes were matched to 2,951 patients without diabetes based on risk factors using propensity score. TPD was categorized as TPD = 0%, 0% < TPD < 1%, 1% ≤ TPD < 5%, 5% ≤ TPD ≤ 10%, and TPD >10%. Major adverse cardiovascular events (MACE) were defined as a composite of all-cause mortality, myocardial infarction, unstable angina, or late revascularization. MACE risk was increased in patients with diabetes compared with patients without diabetes at each level of TPD above 0 ( For every level of TPD >0%, even a very minimal deficit of 0% < TPD < 1%, the MACE risk was higher in the patients with diabetes compared with patients without diabetes. Patients with diabetes with minimal ischemia had comparable MACE risk as patients without diabetes with significant ischemia.

Identifiants

pubmed: 31776140
pii: dc19-1360
doi: 10.2337/dc19-1360
pmc: PMC6971784
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-459

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL089765
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© 2019 by the American Diabetes Association.

Références

Biometrics. 2011 Mar;67(1):39-49
pubmed: 20377575
J Nucl Cardiol. 2020 Jun;27(3):1010-1021
pubmed: 29923104
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Circ Cardiovasc Imaging. 2009 Jul;2(4):290-8
pubmed: 19808609
Stat Med. 1999 Mar 30;18(6):695-706
pubmed: 10204198
J Nucl Med. 2005 Feb;46(2):204-11
pubmed: 15695777
J Nucl Cardiol. 2005 Jan-Feb;12(1):66-77
pubmed: 15682367
Circulation. 2002 Jan 1;105(1):32-40
pubmed: 11772873
J Nucl Cardiol. 2012 Aug;19(4):658-69
pubmed: 22527794
JACC Cardiovasc Imaging. 2018 Jul;11(7):1000-1009
pubmed: 29055639
J Am Coll Cardiol. 2008 Jul 22;52(4):255-62
pubmed: 18634979
JACC Cardiovasc Imaging. 2018 Nov;11(11):1654-1663
pubmed: 29550305
Diabetes Care. 2012 Aug;35(8):1787-94
pubmed: 22699296
J Nucl Cardiol. 2011 Dec;18(6):1003-9; quiz 1010-4
pubmed: 21932154
J Am Coll Cardiol. 2003 Apr 2;41(7):1125-33
pubmed: 12679212
Am Heart J. 1999 Dec;138(6 Pt 1):1025-32
pubmed: 10577431
J Nucl Med. 2009 Apr;50(4):635-43
pubmed: 19339672
Circulation. 2009 Jul 21;120(3):212-20
pubmed: 19581493
JACC Cardiovasc Interv. 2014 Feb;7(2):195-201
pubmed: 24440015
Circulation. 1996 Oct 15;94(8):1818-25
pubmed: 8873655
J Am Coll Cardiol. 2017 Jan 24;69(3):345-357
pubmed: 28104076
JACC Cardiovasc Imaging. 2020 Mar;13(3):774-785
pubmed: 31202740
N Engl J Med. 1998 Jul 23;339(4):229-34
pubmed: 9673301
J Nucl Cardiol. 2018 Oct;25(5):1784-1846
pubmed: 29802599
Diabetes Care. 2004 Dec;27(12):2898-904
pubmed: 15562204
J Nucl Cardiol. 2012 Dec;19(6):1113-23
pubmed: 23065414
J Nucl Med. 2010 Jan;51(1):46-51
pubmed: 20008999
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967

Auteurs

Donghee Han (D)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.

Alan Rozanski (A)

Division of Cardiology, Mount Sinai St. Luke's Hospital, New York, NY.

Heidi Gransar (H)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.

Tali Sharir (T)

Department of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, Israel.
Ben Gurion University of the Negev, Beersheba, Israel.

Andrew J Einstein (AJ)

Division of Cardiology, Departments of Medicine and Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Mathews B Fish (MB)

Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, OR.

Terrence D Ruddy (TD)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.

Albert J Sinusas (AJ)

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.

Edward J Miller (EJ)

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.

Timothy M Bateman (TM)

Cardiovascular Imaging Technologies LLC, Kansas City, MO.

Sharmila Dorbala (S)

Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA.

Marcelo Di Carli (M)

Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA.

Joanna X Liang (JX)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.

Lien-Hsin Hu (LH)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.
Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Guido Germano (G)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.

Damini Dey (D)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.

Daniel S Berman (DS)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.

Piotr J Slomka (PJ)

Division of Nuclear Medicine, Departments of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA piotr.slomka@cshs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH